Note: All prices and reports are based on end of the day (EOD) data.
Glenmark Pharmaceuticals Limited (GLENMARK)
What GLENMARK does

Glenmark Pharmaceuticals Limited

What company does?Pharmaceutical research, development, and manufacturing of generic drugs.
Established1977
Entity typePrivate
HeadquartersIndia
SegmentB2B,B2C
Glenmark Pharmaceuticals Limited is a share market listed company in the Pharmaceuticals industry . It got listed on NSE on 07-FEB-2000 under the trading symbol GLENMARK. On BSE it is listed under trading symbol GLENMARK. The company operates in Pharmaceuticals , Healthcare and Medicine categories.

Company overview

Glenmark Pharmaceuticals Limited is a global pharmaceutical company headquartered in Mumbai, India. The company was founded in 1977 and has since become a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has operations in over 50 countries across six continents with a focus on the research, manufacturing, and marketing of generic drugs, active pharmaceutical ingredients (APIs), and innovative specialty medicines.

Glenmark's product portfolio encompasses a wide range of therapeutic areas including dermatology, respiratory, oncology, cardiovascular, central nervous system disorders, diabetes management, anti-infectives and gastro-intestinal agents. Their offerings include branded formulations as well as generics.

In terms of innovation and technology, Glenmark has been at the forefront of developing novel medications for various ailments. They have focused on creating differentiated products that utilize innovative technologies to enhance patient convenience and efficacy. One aspect that sets Glenmark apart from its competitors is its strong emphasis on research and development. With several R&D centers globally dedicated to discovering breakthrough treatments for unmet medical needs such as cancer or autoimmune diseases – they continue to drive their pipeline forward with an array of promising compounds. Moreover,

the company has established numerous partnerships with leading global pharma companies which enables them to leverage each other's strengths whether it be through licensing agreements or co-marketing arrangements.

Overall,Glenmark Pharmaceuticals Limited stands out due to its commitment towards innovation,research collaborations,and extensive product portfolio catering various therapeutic segments making it one amongst the prominent players within the pharmaceutical industry.
Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.